Claris Lifesciences today said US-based Fresenius Kabi has filed a suit against the company to block commercialisation of its abbreviated new drug application (ANDA) for Propofol, used to induce or maintain anesthesia during surgeries.
The post Fresenius Kabi files suit against Claris Lifesciences over anesthesia drug appeared first on Firstpost.